Invivyd, Inc.
Develops evolution-resistant antibodies to protect against viral diseases like COVID-19 and flu.
IVVD | NDAQ
Overview
Corporate Details
- ISIN(s):
- US00534A1025
- LEI:
- Country:
- United States of America
- Address:
- 209 CHURCH STREET, 6510 NEW HAVEN
- Website:
- https://invivyd.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Invivyd, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for serious infectious diseases. The company utilizes a proprietary integrated technology platform to create potent monoclonal antibodies designed to be resistant to viral evolution. Its pipeline is focused on generating candidates for the prevention and treatment of viral diseases, beginning with COVID-19 and with plans to expand into influenza and other high-need indications. Invivyd aims to deliver protection from evolving viral threats, particularly for vulnerable populations.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Invivyd, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Invivyd, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Invivyd, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
